Aardvark Therapeutics pauses late-stage trial testing rare disease treatment
Feb 27 (Reuters) - Aardvark Therapeutics AARD.O on Friday said it is voluntarily pausing its late-stage trial testing its experimental treatment for a type of rare genetic disease. (Reporting by Sneha S K; Editing by Maju Samuel) ((Sneha.SK@thomsonreuters.com;))